Toltrazuril Paste for Horses with EPM: What Every Owner Should Know

Equine protozoal myeloencephalitis (EPM) is a serious neurologic disease in horses, and the idea of using an antiprotozoal agent like Toltrazuril paste has gained attention. But before you consider this route, it’s critical to understand what the science says, the regulatory status, dosing issues, risks, and best practices. This blog will provide an optimized SEO-friendly deep dive for horse owners, barn managers, and veterinarians.

---

What is EPM?

Equine Protozoal Myeloencephalitis (EPM) is a neurologic disease of horses caused most commonly by the protozoan parasite Sarcocystis neurona (and sometimes Neospora hughesi). The parasite invades the central nervous system, causing ataxia, muscle wasting, gait abnormalities, weakness, and other neurologic signs. Early diagnosis and treatment are key to improving outcome.

---

Why Some Consider Toltrazuril Paste for EPM

Although the U.S. Food and Drug Administration (FDA) has approved certain medications for EPM (for example, Ponazuril paste and Diclazuril) — Toltrazuril is not FDA-approved for use in horses for EPM.

That said, Toltrazuril is used off-label in some countries, and early studies suggest it may have some efficacy and a potentially favourable safety margin. For example:

A 10-day toxicity study in healthy horses given Toltrazuril (50 mg/kg daily) found only mild clinical signs, although this represented 5×–10× anticipated clinical dosage.

Some equine veterinarians and compounding pharmacies market Toltrazuril paste/suspension for horses with EPM. According to one article: “Toltrazuril is considered by some veterinarians as a stronger precursor to Ponazuril… with a broader protozoacidal effect… may cross the blood-brain barrier…”

Thus, for horses that are not responding well to standard therapy, some owners and veterinarians look into Toltrazuril as an alternative or adjunct.

---

Key Considerations Before Using Toltrazuril Paste

✅ Regulatory & Safety Status

The FDA has specifically issued warnings that Toltrazuril is not approved for use in horses for EPM.

Some compounded Toltrazuril/pyrimethamine products have been linked to serious adverse events, including horse deaths, due to dosing errors and unapproved status.

Before considering Toltrazuril, talk with your veterinarian about the regulatory status, sourcing, and legal implications in your region.

⚠️ Dosing & Administration

Because Toltrazuril is off-label for EPM, there is no one widely accepted, FDA-approved dosing regimen in horses for this indication.

The toxicity study gave 50 mg/kg for 10 days and found only mild signs.

Anecdotal information suggests many use 10–20 mg/kg once daily for 28 days, but this is not standardized and must be under veterinary guidance.

Proper dosing depends on accurate weight, formulation, and administration method (oral paste/suspension). Incorrect dosing risks ineffective treatment or toxicity.

🐴 Monitoring & Supportive Care

Given EPM’s neurologic impact, treatment is only part of the care: include physical therapy, controlled exercise, supportive nutrition, and environmental management.

Horses on antiprotozoal therapies may need monitoring of liver/kidney parameters, neurologic signs, and overall progress.

Early intervention improves outcome. Delayed treatment often results in less favourable prognosis.

📋 Pros & Cons

Pros

Potential for broader protozoal effect (per some vets)

Possibly crosses blood-brain barrier better (as claimed in some sources)

May offer alternative when standard therapies fail

Cons

Not FDA-approved in horses for EPM → legal/regulatory risk

Lack of large-scale controlled clinical trials

Risk of sourcing from questionable compounding pharmacies

Potential for side-effects or unforeseen adverse events

---

Best Practices for Horse Owners Considering Toltrazuril Paste

1. Consult a qualified equine veterinarian early. Proper diagnosis, weighing pros/cons of all options, and tailored regimen are essential.

2. Use approved therapies first, unless there’s a good reason to move off-label. For example, Ponazuril is FDA-approved for EPM, dosed at 5 mg/kg daily for 28 days.

3. If using Toltrazuril:

Confirm the formulation (paste/suspension) from a reputable source.

Confirm actual concentration and compatibility with the dose your vet prescribes.

Monitor the horse closely—neurologic status, weight, appetite, gait, vital signs.

4. Address underlying risk factors: reduce exposure to opossums (which carry S. neurona), improve pasture management, avoid stress, feed properly, maintain good general health.

5. Keep realistic expectations: Some horses improve markedly; others only partially recover. Rehabilitation may take months.

6. Record everything: dosage, dates, batch/lot of medication, any side-effects, progress.

7. Avoid treating without diagnosis: Because EPM mimics other neurologic conditions, diagnosis (clinical exam + testing) is crucial.

ClickHere: Buy Toltrazuril Paste